|
WO2010104929A1
|
|
Sulfonamide containing compounds and uses thereof
|
|
WO2010104967A1
|
|
Sulfonamide containing compounds and uses thereof
|
|
WO2010054382A1
|
|
Compounds, compositions, and methods for treating malaria or leishmaniasis
|
|
WO2010051447A1
|
|
Sulfonamide containing compounds and uses thereof
|
|
WO2010022213A2
|
|
Compositions and methods for preserving pancreatic islet mass
|
|
WO2009158646A1
|
|
Therapeutic compounds and related methods of use
|
|
WO2008141189A1
|
|
Ghrelin modulating compounds and combinations thereof
|
|
US2007270473A1
|
|
Sulfonamide compounds and uses thereof
|
|
CN101340903A
|
|
Combinations of metformin and meglitinide
|
|
KR20080086442A
|
|
Combinations of metformin and meglitinide
|
|
EP1931359A2
|
|
Combination therapy for controlled carbohydrate digestion
|
|
CA2611493A1
|
|
Sulfonamide compounds and uses thereof
|
|
EP1865913A1
|
|
Sirt inhibitors that bind to nad
|
|
EP1797090A2
|
|
Sulfonamides and uses thereof
|
|
CN101432004A
|
|
Combination therapy for controlled carbohydrate digestion
|
|
EP1793817A2
|
|
Methods of treating a disorder
|
|
CN101035527A
|
|
Methods of treating a disorder
|
|
AU2005277389A1
|
|
Growth-hormone secretagogues
|
|
US2006292652A1
|
|
Substrate detection assay
|
|
CA2561801A1
|
|
Sulfonamides and uses thereof
|
